Letter to the EditorSafety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19
Keywords
COVID-19
Severe disease
Mortality
Interleukin-1
Anakinra
Canakinumab
Cited by (0)
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.